Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
NCT ID: NCT02951975
Last Updated: 2019-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
246 participants
OBSERVATIONAL
2017-01-25
2018-12-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Effectiveness of Ozurdex for the Control of Uveitis
NCT02049476
Ozurdex Monotherapy Trial
NCT05101928
A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema
NCT01805323
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis
NCT00333814
Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery
NCT01284478
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OZURDEX®
Patients prescribed dexamethasone intravitreal implant (OZURDEX®) in clinical practice for the treatment of non-infectious uveitis affecting the posterior segment of the eye.
dexamethasone intravitreal implant
Dexamethasone intravitreal implant (OZURDEX®) as prescribed in clinical practice.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dexamethasone intravitreal implant
Dexamethasone intravitreal implant (OZURDEX®) as prescribed in clinical practice.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allergan
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathalie Mesnard
Role: STUDY_DIRECTOR
Allergan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens
Amiens, , France
IOP Institut Ophtalmologique de Picardie
Amiens, , France
Centre Rétine Gallien
Bordeaux, , France
Hopital Pellegrin
Bordeaux, , France
CHI de Créteil
Créteil, , France
CHU Dijon
Dijon, , France
Centre Pôle Vision Val d'Ouest
Écully, , France
Hopital Claude Huriez
Lille, , France
Hopital De La Croix Rousse
Lyon, , France
Clinique Monticelli
Marseille, , France
Hopital de la Timone
Marseille, , France
Hopital Gui De Chauliac
Montpellier, , France
SEL Ophtalliance
Nantes, , France
Hopital Hotel Dieu Et Hme
Nantes, , France
CHU Pasteur 2
Nice, , France
Hôpital Lariboisière (AP-HP)
Paris, , France
GH Pitie Salpêtrière (AP-HP)
Paris, , France
GH Cochin St Vincent De Paul (AP-HP)
Paris, , France
Fondation Rothschild
Paris, , France
Hopital La Milétrie
Poitiers, , France
Chu Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bodaghi B, Brezin AP, Weber M, Delcourt C, Kodjikian L, Provost A, Velard ME, Barnier-Ripet D, Pinchinat S, Dupont-Benjamin L. Real-Life Efficacy, Safety, and Use of Dexamethasone Intravitreal Implant in Posterior Segment Inflammation Due to Non-infectious Uveitis (LOUVRE 2 Study). Ophthalmol Ther. 2022 Oct;11(5):1775-1792. doi: 10.1007/s40123-022-00525-8. Epub 2022 Jul 8.
Related Links
Access external resources that provide additional context or updates about the study.
More Information
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GMA-EAME-EYE-0368
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.